Asymchem Laboratories (Tianjin) Co., Ltd. Share Price OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 47.77B 7.16B 6.52B 6.01B 5.46B 10.25B 663B 10.77B 73.1B 29.05B 362B 26.85B 26.29B 1,136B | P/E 2026 * |
37.1x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 43.99B 6.59B 6B 5.53B 5.03B 9.44B 610B 9.92B 67.31B 26.75B 333B 24.72B 24.2B 1,046B | EV / Sales 2026 * |
5.44x | EV / Sales 2027 * | 4.54x |
| Free-Float |
62.23% | Yield 2026 * |
0.97% | Yield 2027 * | 1.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 06/10/1998 |
Rui Yang
CEO | Chief Executive Officer | 49 | 18/01/2022 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 17/07/2011 |
Hao Hong
CHM | Chairman | 70 | 06/10/1998 |
Ye Song
BRD | Director/Board Member | 65 | 17/07/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 7.4B | ||
| -0.30% | -6.68% | +29.12% | +125.42% | 1,204B | ||
| +1.25% | -5.35% | +33.19% | +80.42% | 643B | ||
| +0.94% | -2.99% | +24.73% | +106.93% | 501B | ||
| -0.60% | -2.39% | +27.92% | +67.00% | 378B | ||
| +0.69% | -9.50% | +40.80% | +30.23% | 327B | ||
| +0.41% | -4.81% | +24.99% | +51.91% | 285B | ||
| +0.81% | -3.72% | -1.35% | +30.72% | 270B | ||
| -0.15% | -6.45% | +29.63% | +64.18% | 237B | ||
| -0.06% | -0.98% | +33.15% | +118.99% | 207B | ||
| Average | +0.33% | -4.40% | +26.91% | +75.09% | 450B | |
| Weighted average by Cap. | +0.34% | -4.71% | +27.97% | +87.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.09B 1.21B 1.1B 1.02B 925M 1.74B 112B 1.82B 12.37B 4.92B 61.27B 4.55B 4.45B 192B | 9.83B 1.47B 1.34B 1.24B 1.12B 2.11B 136B 2.22B 15.04B 5.98B 74.45B 5.52B 5.41B 234B |
| Net income | 1.32B 198M 181M 167M 152M 284M 18.38B 299M 2.03B 806M 10.04B 745M 729M 31.51B | 1.78B 266M 243M 224M 203M 382M 24.68B 401M 2.72B 1.08B 13.48B 1B 979M 42.3B |
| Net Debt | -3.79B -567M -517M -476M -433M -812M -52.52B -854M -5.79B -2.3B -28.69B -2.13B -2.08B -90.03B | -2.84B -426M -388M -357M -325M -610M -39.43B -641M -4.35B -1.73B -21.54B -1.6B -1.56B -67.6B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















